Inventor
TAKEUCHI KOHEI
JP16 patents
⚠️ This page may combine multiple inventors who share the name “TAKEUCHI KOHEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TAKEDA PHARMACEUTICALS CO
14 patentsUS10584097B2Mar 10, 2020
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO14 citations94
US10428023B2Oct 1, 2019
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO22 citations94
US11440883B2Sep 13, 2022
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO3 citations73
US11655241B2May 23, 2023
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO2 citations72
US11319286B2May 3, 2022
Heterocyclic compound and application thereof
TAKEDA PHARMACEUTICALS CO4 citations72
US11059780B2Jul 13, 2021
Substituted pyrrolidine compound and use thereof
TAKEDA PHARMACEUTICALS CO4 citations72
US11034700B2Jun 15, 2021
Substituted pyrrolidine compound and use thereof
TAKEDA PHARMACEUTICALS CO4 citations72
US12421188B2Sep 23, 2025
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO0 citations62
US12415782B2Sep 16, 2025
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO0 citations62
US12404237B2Sep 2, 2025
Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives
TAKEDA PHARMACEUTICALS CO0 citations62
US12534471B2Jan 27, 2026
Pyrrolo[1, 2-c]imidazole derivatives as orexin type 2 receptor agonists and methods of use thereof
TAKEDA PHARMACEUTICALS CO0 citations59
US11987586B1May 21, 2024
Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonists
TAKEDA PHARMACEUTICALS CO1 citations59
US12091410B2Sep 17, 2024
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations50
US12071434B2Aug 27, 2024
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations50